Later today, Intellia Vice President, Disease Biology, Sean Burns, M.D., will be presenting at #ASGCT21 about #alpha1 at 5:30 p.m. ET during the Delivery Technologies and #CRISPR for Therapeutics session. #AATD @ASGCTherapy https://t.co/1KKSj3ckIn